MatrixCellect? 100 Putty

Product catalog summary

Introduction
MatrixCellect™ 100 Putty is an innovative allograft bone material introduced by BME, designed to enhance bone grafting procedures. It is composed entirely of demineralized bone matrix (DBM) derived from 100% allograft bone, ensuring superior osteoinductivity and osteoconductivity.

Specifications
- 100% allograft bone with no extrinsic carriers.
- Sterility assurance level (SAL) of 10^-6.
- Available in jar or syringe form, with sizes ranging from 2.5cc to 10.0cc.
- Room temperature storage.

Osteoinductivity and Osteoconductivity
- Proven osteoinductive properties, tested in athymic rats for each lot.
- Functions as a scaffold for new bone growth.
- Post-sterilization testing confirms five elements of bone formation.

Sterility and Quality Standards
- Gamma sterilization performed on every donor lot.
- Exceeds AATB and FDA quality standards.
- Five-year shelf life.

Handling and Technology
- Press Fit Technology™ allows for significant compression and self-anchoring of grafts.
- Stem Cell Containment™ scaffold holds up to 60% of its volume in cellular concentrates.
- Geometric Compression™ ensures proper graft placement.

Product Variants
- Matrix OI Block, Strip, and Filler available in various sizes.
- Soft tissue options include Bone Tendon Bone, Achilles Tendon, and various tendons.

Conclusion
MatrixCellect™ 100 Putty and its family of products offer advanced solutions for bone grafting, providing superior osteoinductive and osteoconductive properties, sterility, and handling capabilities, setting a new standard in medical grafting options.

Catalog excerpts

IT CONFORMS TO YOUR NEEDS. INTRODUCING MATRIXCELLECT™ 1 00 PUTTY 100% ALLOGRAFT BONE - NO EXTRINSIC CARRIERS. SIMPLE. SUPERIOR. STERILE. BME, the leader and innovator in Shape Memory Technologies, introduces an allograft material so superior; it will change the standards for selection. MatrixCellect 100 Putty is Demineralized Bone Matrix (DBM) entirely derived from 100% allograft bone that uses in-vivo assay for conrmation of osteodinductivity. • Histologically proven post sterilization to exhibit ve elements of bone formation • Osteoinductive — Process by which osteogenesis is induced — Testing for osteoinductivity is done in athymic rats, every lot, every time • Osteoconductive — Serves as a scaffold for new bone growth • Sterility assurance level (SAL) 10-6 in accordance with sterile “R” claim • Conforms to ll bone voids or gaps and resists irrigation MATRIXCELLECT 100 PUTTY PRODUCT Toll Free Fax Corporate Email MatrixCellect 100 Putty (Jar) 2.5cc MatrixCellect 100 Putty (Jar) 5.0cc MatrixCellect 100 Putty (Syringe) 10.0cc 14785 Omicron Drive Suite 205 San Antonio, TX 78245 www.bme-tx.com MatrixCellect 100 Putty (Syringe) 5.0cc • Available in jar or syringe for suitability — Arranged for implantation without extra preparation MatrixCellect 100 Putty (Syringe) 2.5cc • Room temperature storage ©2014 MatrixCellect™ 100 is a registered trademark of CellRight™ Technologies, LLC. 1808 Universal City Blvd., San Antonio, TX 78148. Distributed by BME.

Open the catalog to page 1

Family of Matrix OI Products ® MATRIX OI BLOCK PRODUCT OSTEOINDUCTIVITY • In-vivo osteoinductivity testing is performed AFTER gamma sterilization on every donor lot • No other allograft product offers the Matrix OI benchmark for osteoinductivity for this unique family of shape memory products • Matrix OI uses a unique and proprietary process that preserves the inter-connected trabecular collagen structure and the influential “native” Bone Morphogenic Proteins (BMP’s) and growth factors • Osteoinductivity is defined by the confirmed presence of: chondrocytes, osteocytes, bone marrow, cartilage...

Open the catalog to page 2

All BME - BioMedical Enterprises catalogs and technical brochures

Archived catalogs

HammerLock® 2 Simple_Strong_Stable_Effective
4 Pages